Simultaneously, the impact on normal cells and treatment parameters are being established to provide the safety of plasma for biological applications 24,25
and actually SARS-CoV-2 causing COVID-19, all are characterized by persistent inflammation, continuous production of reactive oxygen/nitrogen species and oxidative stress that predominate over the antioxidant defenses (GSH and free radical scavenger enzymes) resulting in cell/tissue/organ aging associated with early (premature) chronic inflammation/inflammaging. We propose that, although inflammaging was introduced for the aging process (276289), it could also apply to early (premature) tissue and organ aging associated with cell and tissue damage caused by excessive oxidative stress and lack of adequate antioxidant defenses, especially low GSH levels, in younger individuals
Apply it once or twice a day depending on your routine
Long-term safety is uncertain
PMC12595317 Badenhorst T, Svirskis D, Merrilees M, et al